ReviewGels (Basel, Switzerland)2025
Polymer Network-Based Nanogels and Microgels: Design, Classification, Synthesis, and Applications in Drug Delivery.
Review in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Development of pH-responsive gelatin/PVP nanogel by gamma radiation for controlled delivery of silibinin.Scientific reports · 2026Article
- Barrier-Oriented Design of Next-Generation Polymeric Nanocarriers for Targeted Drug Delivery.Molecules (Basel, Switzerland) · 2026Review
- Clinical Applications and Therapeutic Potential of Nano-Bio Fusion Gel in Oral Soft Tissue Therapy: A Critical Narrative Review.Gels (Basel, Switzerland) · 2026Review
- Ultrasonic-Responsive Pluronic P105/F127 Nanogels for Overcoming Multidrug Resistance in Cancer.Gels (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polymer network-based nanogels (NGs) and microgels (MGs) have emerged as highly versatile platforms for advanced drug delivery, owing to their tunable architecture, biocompatibility, and responsiveness to diverse stimuli. This review presents a comprehensive and structured analysis of NG/MGs, encompassing their classification based on polymer origin, crosslinking mechanisms, composition, charge, stimuli-responsiveness, and structural architecture. We detail synthesis strategies-including inverse microemulsion and radiation-induced polymerization-and highlight key characterization techniques essential for evaluating physicochemical and functional properties. Emphasis is placed on the design-driven applications of NG/MGs in overcoming biological barriers and enabling targeted therapies, particularly in cancer, inflammation, diabetes, and viral infections. Multifunctional NGs integrating therapeutic and diagnostic capabilities (theranostics), as well as emerging platforms for immunotherapy and personalized medicine, are critically discussed. Finally, we address translational challenges and future directions, including scalable manufacturing, regulatory considerations, and integration with smart diagnostics. This review aims to serve as a foundational resource for researchers and clinicians developing next-generation NG/MG-based therapeutics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.